The Max Foundation shared a post on LinkedIn:
“At 27, Kabitha from rural Nepal was facing mysterious symptoms—crushing fatigue, unexplained bruising, and a sense that something was wrong. Her journey led her to B.P. Koirala Memorial Cancer Hospital, where doctors suspected chronic myeloid leukemia (CML). But without access to costly molecular testing, diagnosis seemed impossible.
Instead of facing the impossible choice between expensive testing in India or going without diagnosis, however, her doctors did something extraordinary: they placed four drops of her blood on a special card and mailed it to Seattle. Weeks later, the results came back with CML confirmed. Treatment could begin immediately. Hope was restored.
This is Spot On CML, a collaboration with the Fred Hutch Cancer Center that’s revolutionizing cancer care in Nepal and beyond. For decades, patients in Nepal faced a devastating paradox: life-saving CML treatments were available, but diagnosis required expensive testing abroad. Spot On CML changed everything.
With just a few drops of blood on a specialized card—no refrigeration, no high-tech labs—samples travel thousands of miles for advanced genetic testing. The result? Access to diagnosis for anyone, anywhere.
Diagnostics aren’t a luxury—they’re the gateway to treatment and survival with dignity.
As Giving Tuesday approaches, we invite you to help us expand access to diagnostics. Because no one should be denied care simply because they were born too far from a lab.”
More posts about The Max Foundation.